BioSpace News Archive

Business

Ligand Enters into Worldwide OmniAb Platform License Agreement with Ferring Pharmaceuticals

Under the license, Ferring will be able to use the full OmniAb platform including OmniRat®, OmniMouse®, OmniFlic® and OmniChicken™ to discover fully human mono- and bispecific antibodies.

January 22, 2018
·
5 min read
Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem (NYSE:ENZ), an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology.

January 22, 2018
·
4 min read
Business

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

The market for cytogenetics media is estimated to exceed $100M annually.

January 22, 2018
·
4 min read
Policy

China FDA Grants Liquid Biopsy Approval to AmoyDx Super-ARMS EGFR Mutation Test

Amoy Diagnostics announced that CFDA approved its Super-ARMS EGFR Mutation Test for use with plasma samples, as a companion diagnostic for NSCLC therapy with EGFR-TKIs on January 19.

January 22, 2018
·
2 min read
BioMidwest

Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

The consensus recommendations point to the need for routine obtainment of family history information and hereditary cancer counselling for men with prostate cancer seen by either a urologist or oncologist.

January 22, 2018
·
6 min read
Biotech Beach

Medeor Therapeutics Awarded $18.8M From the California Institute for Regenerative Medicine

The award is to support a Phase 3 clinical trial to evaluate the safety and efficacy of MDR-101.

January 22, 2018
·
3 min read
Business

Blue Mesa Health to Partner With Merck KGaA, Darmstadt, Germany on Diabetes Prevention Program Pilot Programs Outside of the USA

Founded in 2015, Blue Mesa Health has designed and commercialized two chronic disease prevention programs based on the CDC’s landmark National Diabetes Prevention Program.

January 22, 2018
·
3 min read
Biotech Bay

International Stem Cell Corporation is Valued at $33M Market Value by Edison Investment Research

The report features an analysis of ISCO’s financial data, along with an investment summary that showcases the company’s cell therapy for Parkinson’s disease and Traumatic Brain Injury as a key industry differentiator.

January 22, 2018
·
3 min read
Policy

Orsiro Coronary Drug-Eluting Stent Receives Market Approval in Japan

BIOTRONIK announced today market approval for its Orsiro1 coronary drug-eluting stent by the Japanese Ministry of Health.

January 22, 2018
·
2 min read
Business

Agilent Technologies to Host Webcast of First-Quarter Fiscal Year 2018 Financial Results Conference Call

Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal 2018 financial results after the stock market closes on February 14.

January 22, 2018
·
1 min read